Aesica Pharmaceuticals and CMIC Holdings Co., a Japan-based CDMO with sites in the U.S., have signed an agreement for the mutual development of sales and marketing opportunities for respective clients in Europe and Japan. Both companies will work together to develop commercial opportunities for the U.S. market. This initiative will form the basis of a supply and quality agreement.   Aesica will seek expansion of business opportunities in Japan and the U.S., collaborating with CMIC customers who ...